Analysts Raise Price Targets for UnitedHealth Ahead of Q3 Earnings

Wall Street analysts from Mizuho and Barclays have lifted their price targets for UnitedHealth Group (UNH) ahead of its third-quarter earnings release on October 28. Mizuho's Ann Hynes boosted her target to $430 from $300, while Barclays' Andrew Mok raised his to $386 from $352, both maintaining Buy ratings.

The stock has rebounded 7% over the past month, fueled by Warren Buffett's Berkshire Hathaway disclosing a stake, reaffirmed earnings guidance, and positive updates on Medicare Advantage Star ratings. Despite this, UNH remains down 26% year-to-date as the company's recovery is expected to be gradual.

Earlier concerns—including high medical costs in Medicare Advantage, a DOJ probe, and an unexpected CEO departure—had weighed on performance. The recent uptick reflects growing confidence in UnitedHealth's operational resilience.